X-vir 1 Mg Tablets

Description

What Is X-Vir 1mg Tablet?

X-Vir 1mg Tablet is a potent oral prescription antiviral medication manufactured by Natco Pharma Ltd. Each film-coated tablet contains Entecavir 1 mg.

X-Vir belongs to the pharmacological class of nucleoside reverse transcriptase inhibitors (NRTIs). It is prescribed under specialist medical supervision (gastroenterologist, hepatologist, or infectious disease specialist) for the management of Chronic Hepatitis B Virus (HBV) infection in adult patients with active viral replication and liver disease.

The 1mg strength is primarily reserved for patients who have decompensated liver disease or whose hepatitis B infection has developed resistance to older antiviral medications such as lamivudine.

Quick Product Fact Sheet

• Brand Name: X-Vir 1mg Tablet
• Active Ingredient: Entecavir (1 mg)
• Manufacturer: Natco Pharma Ltd.
• Therapeutic Class: Antiviral agent
• Pharmacological Class: Guanosine nucleoside analogue / NRTI
• Dosage Form: Film-coated oral tablet
• Packaging: Bottle or strip of 30 tablets
• Standard Adult Dose: One 1mg tablet once daily on an empty stomach
• Primary Indication: Chronic Hepatitis B (HBV) with lamivudine resistance or decompensated liver disease

How Does X-Vir 1mg Work?

Entecavir is a synthetic guanosine nucleoside analogue designed to block the Hepatitis B Virus from copying its genetic material inside liver cells (hepatocytes).

Once absorbed into the body, entecavir is converted by cellular enzymes into its active biological form: entecavir triphosphate. Active entecavir triphosphate inhibits all three primary activities of the HBV DNA polymerase enzyme:

• Base Priming: Prevents the initial step required to begin assembling new viral DNA strands.
• Reverse Transcription: Blocks the conversion of viral pregenomic RNA into negative-strand DNA.
• DNA Synthesis: Halts the synthesis of the complementary positive-strand viral DNA.

By blocking these three sequential enzymatic steps, X-Vir effectively shuts down viral replication, lowers the amount of Hepatitis B virus in the blood to undetectable levels, reduces liver inflammation, and helps prevent long-term liver scarring (cirrhosis) and liver cancer.

Approved Clinical Indications

X-Vir 1mg Tablet is indicated for adult patients (18 years of age and older) with chronic hepatitis B virus infection in the following clinical settings:

• Lamivudine-Refractory or Telbivudine-Resistant Hepatitis B: Indicated for patients with evidence of hepatitis B viremia while on lamivudine therapy, or patients with documented lamivudine- or telbivudine-resistant mutations (such as the YMDD mutation).
• Decompensated Liver Disease: Indicated for chronic HBV patients with decompensated liver cirrhosis (advanced liver impairment), regardless of prior treatment history.
• Treatment-Naive Patients with Specific High Viral Loads: While treatment-naive patients with compensated liver disease typically start on entecavir 0.5 mg, certain clinical scenarios require the 1mg tablet under direct specialist direction.

Note: X-Vir is not a permanent cure for Hepatitis B and does not prevent the transmission of HBV to others through sexual contact, sharing needles, or blood exposure.

Standard Dosage and Administration Guidelines

X-Vir 1mg must be taken strictly as prescribed by your treating physician.

• Standard Adult Dose: One 1mg tablet taken orally once daily.
• The Strict Empty-Stomach Requirement: Food significantly delays and reduces the absorption of entecavir. You must take X-Vir on an empty stomach:
  • Take the tablet at least 2 hours before a meal, OR
  • Wait at least 2 hours after your last meal or snack before taking your dose.
• How to Take: Swallow the tablet whole with a full glass of plain water. Do not chew, crush, break, or dissolve the tablet.
• Daily Timing: Take your tablet at the same time every day to keep steady medicine levels in your bloodstream.

Dose Adjustments for Reduced Kidney Function

Entecavir is eliminated primarily through the kidneys. Patients with impaired renal filtration require adjusted dosing intervals:

• 50 mL/min or higher: One 1mg tablet every 24 hours (standard dose)
• 30 to 49 mL/min: One 0.5mg dose daily (or 1mg tablet every 48 hours)
• 10 to 29 mL/min: One 1mg tablet every 72 hours
• Hemodialysis Patients: One 1mg tablet every 7 days (taken immediately following dialysis)

Missed Dose Instructions

• If you miss a dose by less than 12 hours, take it on an empty stomach as soon as you remember.
• If it is within 12 hours of your next scheduled dose, skip the missed dose and resume your regular schedule the following day.
• Never take two tablets at once to make up for a missed dose.

Potential Side Effects & Clinical Management

X-Vir is generally well tolerated, with most side effects being mild and transient.

Common Side Effects

• Nervous System: Headache, fatigue, dizziness, or insomnia (trouble sleeping).
• Digestive: Mild nausea, diarrhea, indigestion, or upper abdominal discomfort.
• Liver Enzymes: Temporary, mild elevations in alanine aminotransferase (ALT) levels as the body clears infected cells.

Serious Warnings

• Severe Hepatitis B Flare-ups (Black Box Warning): Stopping X-Vir abruptly can trigger sudden, severe, and potentially fatal reactivation of the Hepatitis B virus. Never stop taking this medicine without your doctor’s supervision.
• Lactic Acidosis and Severe Fatty Liver: A rare but serious metabolic complication associated with nucleoside analogues. Seek urgent care for deep muscle aches, rapid or difficult breathing, severe stomach pain, cold hands and feet, or sudden extreme fatigue.
• Undiagnosed HIV Resistance Risk: If an individual has an untreated or undiagnosed HIV infection, taking entecavir alone can cause the HIV virus to mutate and develop resistance to other essential HIV medicines.

Precautions & Routine Safety Monitoring

• HBV DNA Viral Load: Baseline, then every 3 to 6 months to track how effectively the virus is being suppressed.
• Liver Function Tests: Baseline, then every 1 to 3 months to monitor for liver enzyme stabilization or sudden inflammatory spikes.
• Kidney Function: Baseline and periodic to determine whether dosing intervals need to be adjusted.
• HIV-1 Antibody Screening: Mandatory prior to starting therapy to confirm absence of HIV.
• Liver Ultrasound / AFP: Every 6 months to screen for early signs of cirrhosis progression or liver tumors.

Drug Interactions & Substance Warnings

• Kidney-Clearing Medicines: Co-administering with drugs that reduce kidney function or compete for renal tubular secretion can raise entecavir blood levels.
• Alcohol: Strictly avoid or minimize alcohol consumption. Alcohol increases liver inflammation and accelerates liver scarring.
• Other Hepatitis B Medicines: Do not combine X-Vir with other entecavir brands, and inform your doctor of any prior treatments with lamivudine, adefovir, or tenofovir.

Special Population Guidance

• Pregnancy: Given only if the potential benefit clearly outweighs the risk to the fetus.
• Breastfeeding: Generally not recommended while on treatment unless approved by a physician.
• Kidney Disease: Dose intervals must be adjusted if creatinine clearance is below 50 mL/min.
• Children: The 1mg tablet is typically designed for adults.

Storage and Handling

• Store tablets at room temperature between 20°C and 25°C (68°F to 77°F).
• Keep tablets in their original packaging, tightly closed, in a dry place protected from direct heat, moisture, and light.
• Keep strictly out of reach of children and pets.

Frequently Asked Questions (FAQs)

Q1: Why was I prescribed X-Vir 1mg instead of the 0.5mg strength?
The 0.5mg strength is standard for patients who have never taken antiviral medications before. The 1mg strength is specifically prescribed for patients whose virus has shown resistance or incomplete response to older drugs like lamivudine, or for patients with advanced decompensated liver disease.

Q2: Why must I take X-Vir on an empty stomach?
Food significantly reduces the amount of entecavir your body absorbs. To ensure the full 1mg dose reaches your bloodstream to fight the virus, you must take it at least 2 hours before or 2 hours after any meal or snack.

Q3: Can I stop taking X-Vir once my viral load becomes undetectable?
No. Reaching an undetectable viral load means the medicine is working successfully to keep the virus suppressed. Stopping the medication allows the virus to multiply again, which can trigger an acute liver flare and severe liver failure.

Q4: Does X-Vir cure Hepatitis B permanently?
X-Vir does not completely remove the dormant viral genetic material (cccDNA) from liver cells, meaning it is not a permanent cure. However, long-term daily suppression stops liver damage, promotes liver healing, and significantly lowers the lifetime risk of cirrhosis and liver cancer.

Medical Disclaimer: This clinical guide is strictly for educational and informational purposes and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified hepatologist, gastroenterologist, or healthcare provider before starting, stopping, or modifying any antiviral therapy.

References

• U.S. Food and Drug Administration (FDA): Baraclude (entecavir) Full Prescribing Information. View Source
• National Center for Biotechnology Information (NCBI): StatPearls Review: Entecavir Pharmacology, Indications, and Clinical Use. View Source
• European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. View Source
• MedlinePlus (U.S. National Library of Medicine): Entecavir Monograph & Patient Instructions. View Source